BACPHAR logo

Bacil Pharma Ltd

BACPHAR·BSE·
15.30 +0.72 (+4.94%)
Market Cap19.94 Cr
PE Ratio54.64
Volume19,942
Day High - Low15.30 - 14.65
52W High-Low61.80 - 10.65
DocStoX Score
2.0/10
Poor
Fair Value
Sign in to see
ROE
6.21%
Weak
P/E
54.64x
Expensive
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day14.65
15.30
52W10.65
61.80
DocStoX take

Held back by momentum (0.0). Scored on 4 of 5 measures.

DocStoX score

Low confidence
2.0
/10
Poor
Quality
Weak
ROE 6.2%
Valuation
Rich
P/E 54.6×
Growth
No data
No multi-year history
Risk
Moderate
D/E 0.00
Momentum
Weak
9% of 52-week range

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹20 Cr
52W High / Low
₹62 / ₹11
Dividend Yield
0.00%
Promoter Holding
0.00%
EPS (TTM)
₹0.28
Book Value
₹17.55

Key highlights

  • Low leverage — D/E 0.00
  • Loss-making in some of the last 5 years
  • Quality is weak (1.0/10)
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Bacil Pharma Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.